NervGen Pharma (NGENF) Stock Chart & Stock Price History $3.11 +0.05 (+1.76%) As of 10/7/2025 03:55 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock NervGen Pharma Stock Price Performance The NervGen Pharma (NGENF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 75.93%, with a year-to-date return of 42.84%. In the past month, the stock has increased 16.63%, reflecting recent market activity. As of the latest close, NervGen Pharma traded at $3.11 with a market cap of $192.35 million and volume of 183,870 shares. Five years ago, the stock traded at $1.04, representing a 199.42% increase over that period. At the time, it had a market cap of $64.07 million and a volume of 17,878 shares. Receive NGENF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NervGen Pharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+2.77%1 Month Performance+16.63%3 Month Performance+20.70%Year-To-Date Performance+42.84%1 Year Performance+75.93%5 Year Performance+199.42% NGENF Stock Chart for Wednesday, October, 8, 2025 NGENF Chart by TradingView NervGen Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/07/2025$3.06$3.11+1.76%$3.17$3.00183,870 shs$192.35 million10/06/2025$3.03$3.06+0.99%$3.15$2.78514,105 shs$189.02 million10/03/2025$2.56$3.03+18.17%$3.41$2.591.31 million shs$187.16 million10/02/2025$2.52$2.56+1.58%$2.59$2.5151,910 shs$158.38 million10/01/2025$2.36$2.52+6.95%$2.60$2.3546,870 shs$155.91 million09/30/2025$2.35$2.36+0.43%$2.39$2.34100,103 shs$145.78 million09/29/2025$2.35$2.35$2.50$2.35126,659 shs$145.16 million09/26/2025$2.43$2.35-3.29%$2.48$2.3140,350 shs$145.16 million09/25/2025$2.54$2.43-4.33%$2.54$2.4343,407 shs$150.10 million09/24/2025$2.58$2.54-1.44%$2.58$2.5034,101 shs$156.90 million Get the Latest News and Ratings for NGENF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NervGen Pharma and its competitors with MarketBeat's FREE daily newsletter. 09/23/2025$2.54$2.58+1.38%$2.60$2.5536,259 shs$159.19 million09/22/2025$2.58$2.54-1.47%$2.60$2.5251,978 shs$157.02 million09/19/2025$2.63$2.58-1.83%$2.70$2.5644,506 shs$159.37 million09/18/2025$2.66$2.63-1.28%$2.69$2.6344,826 shs$162.33 million09/17/2025$2.71$2.66-1.77%$2.72$2.6569,803 shs$164.43 million09/16/2025$2.77$2.71-2.17%$2.79$2.7145,804 shs$167.40 million09/15/2025$2.65$2.77+4.53%$2.90$2.69117,281 shs$171.10 million09/12/2025$2.65$2.65$2.76$2.6023,283 shs$163.69 million09/11/2025$2.64$2.65+0.38%$2.72$2.6327,229 shs$163.69 million09/10/2025$2.68$2.64-1.49%$2.71$2.6025,622 shs$163.07 million09/09/2025$2.67$2.68+0.37%$2.87$2.6767,746 shs$165.54 million09/08/2025$2.73$2.67-2.20%$2.87$2.6529,221 shs$164.93 million Related Companies CYBN Stock Chart APHB Stock Chart HYPD Stock Chart IBIO Stock Chart HEB Stock Chart PHGE Stock Chart BRTX Stock Chart PHXM Stock Chart ADIL Stock Chart SPRBD Stock Chart Receive NGENF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NervGen Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:NGENF) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NervGen Pharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share NervGen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
